Our previous studies have shown that EGFR can exist in two statuses in cancer cells, a kinase responsive status that governs the classical EGFR’s kinase-dependent functions and a kinase-independent status that maintains cell survival by interacting with crucial pro-survival proteins such the sodium/glucose co-transporter 119. The gene discussed is EGFR; the disease is cancer.